These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 17295083

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Extremity soft tissue sarcoma: adding to the prognostic meaning of local failure.
    Gronchi A, Miceli R, Fiore M, Collini P, Lozza L, Grosso F, Mariani L, Casali PG.
    Ann Surg Oncol; 2007 May; 14(5):1583-90. PubMed ID: 17260106
    [Abstract] [Full Text] [Related]

  • 3. [Choice of treatment tactics for the recurrence of soft tissue malignant tumor].
    Korzhikov AV, Lapshin IM, Anfilov SV, Fedosiuk AM, Seriakov AP.
    Voen Med Zh; 2005 Nov; 326(11):26-31. PubMed ID: 16404903
    [No Abstract] [Full Text] [Related]

  • 4. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance.
    Massi D, Beltrami G, Capanna R, Franchi A.
    Eur J Surg Oncol; 2004 Dec; 30(10):1131-6. PubMed ID: 15522563
    [Abstract] [Full Text] [Related]

  • 5. Local recurrence and survival in soft tissue sarcomas: the relation of biopsy.
    Thompson RC, Hartman R, Swanson P, Dusenbury K.
    Chir Organi Mov; 1990 Dec; 75(1 Suppl):131-3. PubMed ID: 2249508
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Malignant tumours of the locomotor apparatus in children: an "intermediate" prognosis].
    Orbach D, Glorion C, Mary P, Freneaux P, Brisse H, Helfre S, Schleiermacher G, Pacquement H.
    Rev Prat; 2007 May 31; 57(10):1080-6. PubMed ID: 17844801
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic factors in soft tissue sarcoma. A review and the Scandinavian Sarcoma Group experience.
    Rydholm A, Gustafson P, Alvegård TA, Saeter G, Blomqvist C.
    Acta Orthop Scand Suppl; 1999 Jun 31; 285():50-7. PubMed ID: 10429623
    [No Abstract] [Full Text] [Related]

  • 12. Should patients with high-risk soft tissue sarcoma receive adjuvant chemotherapy?
    Schuetze SM, Patel S.
    Oncologist; 2009 Oct 31; 14(10):1003-12. PubMed ID: 19808770
    [Abstract] [Full Text] [Related]

  • 13. Prognostic factors in soft-tissue sarcomas: what have we learnt?
    Choong PF, Rüdiger HA.
    Expert Rev Anticancer Ther; 2008 Feb 31; 8(2):139-46. PubMed ID: 18279053
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Prognostic factors in soft tissue sarcoma in the adult].
    Guillou L, Coindre JM.
    Ann Pathol; 1997 Dec 31; 17(6):375-7. PubMed ID: 9526622
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The biological significance of failure at the primary site on ultimate survival in soft tissue sarcoma.
    Espat NJ, Lewis JJ.
    Semin Radiat Oncol; 1999 Oct 31; 9(4):369-77. PubMed ID: 10516384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.